Loading organizations...
Loading organizations...
Biopharmaceutical company developing drugs for protein misfolding diseases.
Wren Therapeutics has raised $40.2M across 2 funding rounds.
Wren Therapeutics has raised $40.2M in total across 2 funding rounds.
Wren Therapeutics has raised $40.2M in total across 2 funding rounds.
Wren Therapeutics's investors include Baupost Group, Industry Ventures, LifeForce Capital, Schooner Capital.
Wren Therapeutics has raised $40.2M across 2 funding rounds. Most recently, it raised $17.0M Other Equity in January 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 25, 2021 | $17.0M Other Equity | Baupost Group | Industry Ventures, LifeForce Capital, Schooner Capital |
| Jan 22, 2019 | $23.2M Series A | Baupost Group | LifeForce Capital |